Journal History

2012 The inaugural issue was released. Antibodies was published as a quarterly journal.
2014 Antibodies was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1).
2019 Antibodies was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 5 (Issue 1).
2021 Antibodies was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1).
2022

Antibodies received its first CiteScore (2021) of 0.9.

Antibodies established the following sections:
Antibody Discovery and Engineering;
Antibody-Based Therapeutics
;
Antibody-Based Diagnostics
;
Humoral Immunity
.

2023

Antibodies received its first Impact Factor 4.7, ranked 2/16 in the category “Immunology” in ESCI.

Antibodies received its second CiteScore (2022) of 9.6.

2024

Antibodies received its 2023 Impact Factor (3.0), ranked 105/181 in the category “Immunology”.
Antibodies received its CiteScore (2023) of 7.1.

Editor-in-Chief

2011–2014 Editor-in-Chief: Prof. Dr. Tomohiro Kurosaki
2014–2022 Editor-in-Chief: Prof. Dr. Dimiter S. Dimitrov
2022–present Editor-in-Chief: Prof. Dr. Arne Skerra

Section Editor-in-Chief

2022–present Section Editor-in-Chief: Prof. Dr. Linqi Zhang for the section on Humoral Immunity
Back to TopTop